Home
About OBIO
OBIO Governance
Our Vision and Mission
Board of Directors
Contact Us
Membership
Sponsorship
Founding Sponsors
2011 Sponsors
Becoming a Sponsor
OBEST™
OBEST E-Room
OBEST™ Strategy Report
OBEST™ Strategy Report Presentation
Featured Articles
OBIO News & Events
Press Releases
Reports
Founding Sponsors
Gold
Amgen
Equicom
HealthComm
Silver
Merck Frosst
Rx&D
Gowlings
PwC
Bronze
RBC
Astra Zeneca
Dalton Pharma Services
Dalton Medicinal Chemistry
Pfizer
Supporter
VWR
Recent Posts
OBEST Teams Announced at OBIO 2011 AGM
Bioscience Industry Leaders Discuss Issues That Matter
CEO-LED ADVOCACY WINS $3-MILLION FINANCING
Commercialization Success OBEST
Nine-point strategy for growth and sustainability
The Ontario Bioscience Industy Strategic Implementation Plan
Ontario’s Bioscience Industry – Translating Strategy into Action
Leveraging the $7 Million Fund – Designated for Ontario Bioscience Companies Announced in May 2010
The Best Laid Plans – How OBIO™ is looking to overcome the past, change the course of the bioscience industry in Ontario and steer the ship out of the storm
Sustainability and Growth in 2011 and beyond
Tags
access to capital
BIOTECanada
biotechnology industry
government of ontario
healthcare
obio
ontario
operations
people